In a more recent study [44], it was observed that neither PON1 activity nor the HDL-associated enzymes myeloperoxidase (MPO) and lecithin-cholesterol acyltransferase (LCAT) differed in stages 3a 3b and 4 of CKD. This evidence concerns the gene PON1 and chronic kidney disease.